
WB analysis of Jurkat cells using GTX45949 ST6GALNAC5 antibody at 1.25microg/ml.
ST6GALNAC5 antibody, Internal
GTX45949
Overview
- SupplierGeneTex
- Product NameST6GALNAC5 antibody, Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 0.2-2.5 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5-1 mg/ml
- ConjugateUnconjugated
- Gene ID81849
- Target nameST6GALNAC5
- Target descriptionST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
- Target synonymsalpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase V; alpha-N-acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase E; GalNAc alpha-2,6-sialyltransferase V; GD1 alpha synthase; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) E; sialyltransferase 7E; SIAT7E; SIAT7-E; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; ST6 GalNAc alpha-2,6-sialyltransferase 5; ST6 neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; ST6GalNAc V; ST6GalNAcV
- HostRabbit
- IsotypeIgG
- Protein IDQ9BVH7
- Protein NameAlpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
- Scientific DescriptionThe protein encoded by this gene is a Golgi type II transmembrane glycosyltransferase. The encoded protein catalyzes the transfer of sialic acid to cell surface proteins to modulate cell-cell interactions. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids. Su YH et al., 2018 Apr 17, OncotargetRead more